Oppenheimer & Co’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.4M Buy
22,621
+2,991
+15% +$1.51M 0.13% 169
2025
Q4
$11.1M Sell
19,630
-1,877
-9% -$999K 0.16% 146
2025
Q3
$9.62M Sell
21,507
-440
-2% -$211K 0.12% 184
2025
Q2
$11.9M Buy
21,947
+1,724
+9% +$901K 0.16% 142
2025
Q1
$10M Buy
20,223
+2,438
+14% +$1.35M 0.15% 148
2024
Q4
$9.28M Sell
17,785
-560
-3% -$292K 0.14% 152
2024
Q3
$9.01M Sell
18,345
-720
-4% -$335K 0.14% 164
2024
Q2
$8.48M Sell
19,065
-1,797
-9% -$716K 0.13% 162
2024
Q1
$8.33M Buy
20,862
+6,960
+50% +$2.63M 0.14% 167
2023
Q4
$4.69M Buy
13,902
+1,597
+13% +$476K 0.09% 269
2023
Q3
$3.6M Buy
12,305
+2,873
+30% +$897K 0.07% 301
2023
Q2
$3.23M Buy
9,432
+2,141
+29% +$648K 0.06% 334
2023
Q1
$1.86M Buy
7,291
+110
+2% +$27.1K 0.04% 466
2022
Q4
$1.91M Sell
7,181
-4,200
-37% -$1.02M 0.04% 460
2022
Q3
$2.13M Buy
11,381
+1,411
+14% +$303K 0.05% 410
2022
Q2
$2M Sell
9,970
-3,265
-25% -$766K 0.04% 460
2022
Q1
$3.99M Sell
13,235
-522
-4% -$152K 0.07% 323
2021
Q4
$4.94M Sell
13,757
-196
-1% -$67.4K 0.09% 271
2021
Q3
$4.62M Buy
13,953
+702
+5% +$236K 0.09% 269
2021
Q2
$4.06M Buy
13,251
+990
+8% +$278K 0.07% 318
2021
Q1
$3.02M Sell
12,261
-2,520
-17% -$634K 0.06% 355
2020
Q4
$4.03M Buy
14,781
+5,949
+67% +$1.48M 0.09% 270
2020
Q3
$2.09M Buy
8,832
+3,168
+56% +$711K 0.05% 378
2020
Q2
$1.08M Sell
5,664
-1,437
-20% -$258K 0.03% 551
2020
Q1
$1.17M Sell
7,101
-4,350
-38% -$797K 0.04% 471
2019
Q4
$2.26M Buy
11,451
+420
+4% +$78.6K 0.06% 380
2019
Q3
$1.99M Sell
11,031
-864
-7% -$149K 0.05% 397
2019
Q2
$2.08M Sell
11,895
-16,443
-58% -$2.82M 0.06% 389
2019
Q1
$5.39M Buy
28,338
+12,189
+75% +$2.17M 0.14% 156
2018
Q4
$2.58M Sell
16,149
-6,486
-29% -$1.1M 0.08% 279
2018
Q3
$4.33M Buy
22,635
+6,948
+44% +$1.23M 0.11% 202
2018
Q2
$2.5M Sell
15,687
-2,304
-13% -$351K 0.07% 333
2018
Q1
$2.48M Buy
17,991
+1,908
+12% +$266K 0.06% 340
2017
Q4
$1.96M Buy
16,083
+1,863
+13% +$233K 0.05% 398
2017
Q3
$1.65M Buy
14,220
+6,606
+87% +$720K 0.04% 438
2017
Q2
$791K Sell
7,614
-1,701
-18% -$163K 0.02% 677
2017
Q1
$793K Buy
9,315
+3,375
+57% +$267K 0.02% 648
2016
Q4
$419K Buy
5,940
+2,187
+58% +$161K 0.01% 867
2016
Q3
$302K Buy
3,753
+342
+10% +$26.2K 0.01% 984
2016
Q2
$251K Buy
+3,411
New +$240K 0.01% 1027
2014
Q1
Sell
-16,281
Closed -$695K 1440
2013
Q4
$695K Sell
16,281
-8,208
-34% -$345K 0.02% 700
2013
Q3
$1.02M Buy
24,489
+7,083
+41% +$313K 0.04% 525
2013
Q2
$979K Buy
+17,406
New +$959K 0.04% 524

Other funds holding ISRG

Oppenheimer & Co's ISRG Position: Q1 2026 in Review

Oppenheimer & Co increased its Intuitive Surgical (ISRG) stake by 15% in Q1 2026, buying an estimated $1.51M and bringing the position to 22,621 shares worth $10.4M. The position accounts for 0.13% of the portfolio, ranked #169.

Oppenheimer & Co first reported a position in ISRG in Q2 2013 and has held it in 43 quarters since. The position peaked at $11.9M in Q2 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Oppenheimer & Co held 22,621 shares of Intuitive Surgical worth $10.4M as of Q1 2026.
  • Oppenheimer & Co bought 2,991 Intuitive Surgical shares in Q1 2026, an estimated $1.51M.
  • Intuitive Surgical made up 0.13% of Oppenheimer & Co's portfolio in Q1 2026, its #169 holding.
  • Oppenheimer & Co first reported a position in Intuitive Surgical in Q2 2013 and has held it in 43 quarters since.
  • Oppenheimer & Co's Intuitive Surgical position peaked at $11.9M in Q2 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.